Huang 2010.
Study characteristics | ||
Methods | Randomised clinical trial | |
Participants | Country: China Number randomised: 230 Postrandomisation dropouts: 0 (0%) Revised sample size: 230 Average age: 56 years Females: 66 (28.7%) Cirrhosis: 142 (61.7%) Very early HCC: not stated Portal hypertension: not stated Viral aetiology: 215 (93.5%) Immunotherapy/antiviral adjuvant therapy: not stated Average follow‐up period in months (for all groups): median: 42 months Criteria for early or very early HCC and other inclusion criteria:
|
|
Interventions | Participants were randomly assigned to 2 groups: Group 1: surgery (n = 115). Further details: not stated whether open or laparoscopic resection. Group 2: radiofrequency ablation (n = 115). Further details: radiofrequency ablation using Cool‐tip (Radionics). | |
Outcomes | The outcomes reported were:
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "randomization method with a computer" |
Allocation concealment (selection bias) | Low risk | Quote: "Physicians received the envelope for each patient in the registry sequence kept in a container given by the statistician and kept by the chief nurse of our center." |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Quote: "Because of the nature of the interventions, the double‐blind technique was not used" |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Quote: "Because of the nature of the interventions, the double‐blind technique was not used" |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: there were no postrandomisation dropouts. |
Selective reporting (reporting bias) | Low risk | Comment: important clinical outcomes were reported. |
For‐profit bias | Low risk | Quote: "This study has not received any support from industry or private corporations." |
Other bias | Low risk | Comment: no other bias noted. |